HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Chiravuri, M. Articles by Huber, B. T. Search for Related Content PubMed PubMed Citation Articles by Chiravuri, M. Articles by Huber, B. T.

A Novel Apoptotic Pathway in Quiescent Lymphocytes Identified by Inhibition of a Post-Proline Cleaving Aminodipeptidase: A Candidate Target Protease, Quiescent Cell Proline Dipeptidase¹

Department of Pathology, Program in Immunology, Tufts University School of Medicine, Boston, MA 02111

The vast majority of lymphocytes in vivo persist in a quiescent state. These resting lymphocytes are maintained through a cellular program that suppresses apoptosis. We show here that quiescent PBMC, but not activated PBMC or transformed lymphocytes, die in the presence of highly specific post-proline aminodipeptidase inhibitors. This form of death has the hallmarks of apoptosis, such as phosphatidylserine externalization and loss of mitochondrial transmembrane potential. However, it differs from apoptosis induced by gamma irradiation in the same cells or by Fas ligation in transformed lymphocytes in terms of caspase involvement. In addition, the aminodipeptidase inhibitor-induced cell death, but not gamma-irradiation-mediated apoptosis, can be prevented by inhibition of the proteasome complex. The target of these inhibitors is not CD26/DPPIV, but probably a novel serine protease, quiescent cell proline dipeptidase, that we have recently isolated and cloned. These studies will yield a better understanding of the requirements and the mechanisms that mediate quiescent lymphocyte homeostasis in vivo.

This article has been cited by other articles:

				E. Boonacker, S. Elferink, A. Bardai, B. Fleischer, and C. J.F. Van Noorden Fluorogenic Substrate [Ala-Pro]2-Cresyl Violet But Not Ala-Pro-Rhodamine 110 Is Cleaved Specifically by DPPIV Activity: A Study in Living Jurkat Cells and CD26/DPPIV-transfected Jurkat Cells J. Histochem. Cytochem., July 1, 2003; 51(7): 959 - 968. [Abstract] [Full Text] [PDF]

				M. Chiravuri, F. Agarraberes, S. L. Mathieu, H. Lee, and B. T. Huber Vesicular Localization and Characterization of a Novel Post-Proline-Cleaving Aminodipeptidase, Quiescent Cell Proline Dipeptidase J. Immunol., November 15, 2000; 165(10): 5695 - 5702. [Abstract] [Full Text] [PDF]

				R. Underwood, M. Chiravuri, H. Lee, T. Schmitz, A. K. Kabcenell, K. Yardley, and B. T. Huber Sequence, Purification, and Cloning of an Intracellular Serine Protease, Quiescent Cell Proline Dipeptidase J. Biol. Chem., November 26, 1999; 274(48): 34053 - 34058. [Abstract] [Full Text] [PDF]

				M. Chiravuri, H. Lee, S. L. Mathieu, and B. T. Huber Homodimerization via a Leucine Zipper Motif Is Required for Enzymatic Activity of Quiescent Cell Proline Dipeptidase J. Biol. Chem., August 25, 2000; 275(35): 26994 - 26999. [Abstract] [Full Text] [PDF]

				D. Marguet, L. Baggio, T. Kobayashi, A.-M. Bernard, M. Pierres, P. F. Nielsen, U. Ribel, T. Watanabe, D. J. Drucker, and N. Wagtmann Enhanced insulin secretion and improved glucose tolerance in mice lacking CD26 PNAS, June 6, 2000; 97(12): 6874 - 6879. [Abstract] [Full Text] [PDF]